Skip to main content
Top
Published in: Drugs 5/2003

01-03-2003 | Therapy in Practice

Diagnosis and Treatment of Patients with Pouchitis

Author: Dr Bo Shen

Published in: Drugs | Issue 5/2003

Login to get access

Abstract

Pouchitis is the most common long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis. Clinical symptoms of pouchitis are not specific, and they can be caused by other conditions such as rectal cuff inflammation and irritable pouch syndrome. Therefore, to make an accurate diagnosis, endoscopic evaluation together with symptom assessment is necessary. Among five available treat-first and test-first strategies, the initial approach with pouch endoscopy without histology was the most cost-effective strategy for the diagnosis of pouchitis. On the basis of clinical course, pouchitis can be classified into acute, relapsing and chronic forms. Pouchitis can also be classified into three categories based on the response to antibacterial therapy: (i) antibacterial-responsive; (ii) antibacterial-dependent; and (iii) antibacterial-resistant. Metronidazole and ciprofloxacin are both effective in treating acute pouchitis. Although antibacterial therapy can induce and maintain remission, probiotics such as VSL#3 can also be used as to maintain clinical remission and prevent relapse in patients with relapsing or chronic pouchitis. For patients with chronic pouchitis that is resistant to antibacterials, therapy with anti-inflammatory agents and immunomodulators is often required.
Footnotes
1
Use of tradenames is for identification purposes only and does not imply endorsement.
 
Literature
1.
go back to reference Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856–60PubMed Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856–60PubMed
3.
go back to reference Fazio VW, Ziv Y, Church JM, et al. Heal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 1995; 222: 120–7PubMedCrossRef Fazio VW, Ziv Y, Church JM, et al. Heal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 1995; 222: 120–7PubMedCrossRef
4.
go back to reference Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9PubMedCrossRef Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9PubMedCrossRef
5.
go back to reference Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205–29PubMedCrossRef Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205–29PubMedCrossRef
6.
go back to reference Lohmuller JL, Perberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622–9PubMed Lohmuller JL, Perberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622–9PubMed
7.
go back to reference Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765–7PubMedCrossRef Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765–7PubMedCrossRef
8.
go back to reference Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322–5PubMedCrossRef Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322–5PubMedCrossRef
9.
go back to reference Dozois RR, Goldberg SM, Rothenberger DA, et al. Workshop: pouchitis. Int J Colorectal Dis 1986; 1: 2–19PubMedCrossRef Dozois RR, Goldberg SM, Rothenberger DA, et al. Workshop: pouchitis. Int J Colorectal Dis 1986; 1: 2–19PubMedCrossRef
10.
go back to reference Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654–65PubMedCrossRef Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654–65PubMedCrossRef
11.
go back to reference Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcomes in 1310 patients. Br J Surg 1998; 85: 800–3PubMedCrossRef Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcomes in 1310 patients. Br J Surg 1998; 85: 800–3PubMedCrossRef
12.
go back to reference Yang T, Oresland T, Jarnerot G, et al. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996; 31: 594–8PubMedCrossRef Yang T, Oresland T, Jarnerot G, et al. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996; 31: 594–8PubMedCrossRef
13.
go back to reference Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740–7PubMed Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740–7PubMed
14.
go back to reference Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671–7PubMedCrossRef Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671–7PubMedCrossRef
15.
go back to reference Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261–7PubMedCrossRef Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261–7PubMedCrossRef
16.
go back to reference Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology 1993; 104: 981–8PubMed Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology 1993; 104: 981–8PubMed
17.
go back to reference Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167–74PubMedCrossRef Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167–74PubMedCrossRef
18.
go back to reference Petras RE. Role of the pathologist in evaluating chronic pouchitis. In: Bayless TM, Hanauer SB, editors. Advanced therapy of inflammatory bowel disease. 1st ed. Hamilton, (ON): BC Decker, 2001: 229–32 Petras RE. Role of the pathologist in evaluating chronic pouchitis. In: Bayless TM, Hanauer SB, editors. Advanced therapy of inflammatory bowel disease. 1st ed. Hamilton, (ON): BC Decker, 2001: 229–32
19.
go back to reference Pemberton JH. The problem with pouchitis [editorial]. Gastroenterology 1993; 104: 1209–11PubMed Pemberton JH. The problem with pouchitis [editorial]. Gastroenterology 1993; 104: 1209–11PubMed
20.
go back to reference Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972–7PubMedCrossRef Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972–7PubMedCrossRef
21.
go back to reference Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487–99PubMedCrossRef Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487–99PubMedCrossRef
22.
go back to reference Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409–15PubMedCrossRef Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409–15PubMedCrossRef
23.
go back to reference Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8PubMedCrossRef Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8PubMedCrossRef
24.
go back to reference Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9PubMedCrossRef Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9PubMedCrossRef
25.
go back to reference Tremaine WJ, Sandborn WJ, Wolff BG, et al. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997; 11: 1041–6PubMedCrossRef Tremaine WJ, Sandborn WJ, Wolff BG, et al. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997; 11: 1041–6PubMedCrossRef
26.
go back to reference Shen B, Achkar JP, Lashner BA, et al. A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001; 7: 301–5PubMedCrossRef Shen B, Achkar JP, Lashner BA, et al. A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001; 7: 301–5PubMedCrossRef
27.
go back to reference Gionchetti P, Rizzollo F, Venturi A, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial [abstract]. Gastroenterology 2000; 118: A1214CrossRef Gionchetti P, Rizzollo F, Venturi A, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial [abstract]. Gastroenterology 2000; 118: A1214CrossRef
28.
go back to reference Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40: 1474–83PubMedCrossRef Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40: 1474–83PubMedCrossRef
29.
go back to reference Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27–34PubMedCrossRef Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27–34PubMedCrossRef
30.
go back to reference Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification, and public health prospective. In: McLeod RS, Martin F, Sutherland LR, et al., editors. Trends in inflammatory bowel disease 1996. Lancaster, UK: Kluwer Academic Publishers, 1997: 51–63 Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification, and public health prospective. In: McLeod RS, Martin F, Sutherland LR, et al., editors. Trends in inflammatory bowel disease 1996. Lancaster, UK: Kluwer Academic Publishers, 1997: 51–63
31.
go back to reference Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia (PA): WB Saunders Company, 1999: 736–47 Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia (PA): WB Saunders Company, 1999: 736–47
32.
go back to reference Shen B, Lashner BA, Achkar JP, et al. Modified pouchitis disease activity index (mPDAI): a new approach to the diagnosis of pouchitis. Dis Colon Rectum. In press Shen B, Lashner BA, Achkar JP, et al. Modified pouchitis disease activity index (mPDAI): a new approach to the diagnosis of pouchitis. Dis Colon Rectum. In press
33.
go back to reference Shen B, Shermock KM, Achkar JP, et al. A cost-effectiveness analysis of diagnostic strategies in symptomatic patients with ileal pouch-anal anastomosis [abstract]. Am J Gastroenterol 2001; 96: A975 Shen B, Shermock KM, Achkar JP, et al. A cost-effectiveness analysis of diagnostic strategies in symptomatic patients with ileal pouch-anal anastomosis [abstract]. Am J Gastroenterol 2001; 96: A975
34.
go back to reference Ricart E, Panccione R, Loftus EV, et al. Successful management of Crohn disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 429–32PubMedCrossRef Ricart E, Panccione R, Loftus EV, et al. Successful management of Crohn disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 429–32PubMedCrossRef
35.
go back to reference Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193–6PubMedCrossRef Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193–6PubMedCrossRef
36.
go back to reference Mignon M, Stettier C, Philips SF. Pouchitis: a poorly understood entity. Dis Colon Rectum 1995; 38: 100–3PubMedCrossRef Mignon M, Stettier C, Philips SF. Pouchitis: a poorly understood entity. Dis Colon Rectum 1995; 38: 100–3PubMedCrossRef
37.
go back to reference Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000; 119: 584–5PubMedCrossRef Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000; 119: 584–5PubMedCrossRef
38.
go back to reference Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497–502PubMedCrossRef Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497–502PubMedCrossRef
39.
go back to reference Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135: 463–5PubMedCrossRef Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135: 463–5PubMedCrossRef
40.
go back to reference Hurst RD, Chung TP, Rubin M, et al. Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280–4PubMed Hurst RD, Chung TP, Rubin M, et al. Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280–4PubMed
41.
go back to reference Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46: 334–7PubMed Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46: 334–7PubMed
42.
go back to reference Wischmeyer P, Pemberton JH, Philips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978–81PubMedCrossRef Wischmeyer P, Pemberton JH, Philips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978–81PubMedCrossRef
43.
go back to reference Gionchetti P, Rizzello R, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8PubMedCrossRef Gionchetti P, Rizzello R, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8PubMedCrossRef
44.
go back to reference Mimura T, Rizzello R, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-17PubMedCrossRef Mimura T, Rizzello R, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-17PubMedCrossRef
Metadata
Title
Diagnosis and Treatment of Patients with Pouchitis
Author
Dr Bo Shen
Publication date
01-03-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue 5/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363050-00002

Other articles of this Issue 5/2003

Drugs 5/2003 Go to the issue

Adis Drug Profile

Imatinib Mesylate

Adis Drug Profile

Imatinib Mesylate

Adis Drug Profile

Imatinib Mesylate